摘要
异基因造血干细胞移植 (Allo HSCT)因具有独特的移植物抗恶性病效应常用来治疗某些恶性血液病 ,近年来Allo HSCT在临床上尝试性地用来治疗某些实体瘤并取得了一定的疗效 ,现就Allo
Allogeneic hematopoietic stem cell transplantation(Allo-HSCT) has proved to have a unique immune-mediated antitumor effect in patients with hematologic malignancies. However,recently more investigators have come to recognize that antineoplastic effect mediated by immunopotent donor T-cells transplanted with the stem cell allograft can be induced against solid malignancies and achieved some therapeutic effect.This article reviews the graft-versus-tumor effect and its immunotherapeutic mechanism to investigate the potential of allogeneic immunotherapy for treating solid tumor.
出处
《东南大学学报(医学版)》
CAS
2004年第4期282-285,共4页
Journal of Southeast University(Medical Science Edition)
关键词
移植物
抗肿瘤效应
实体瘤
治疗
免疫机制
异基因造血干细胞移植
hematopoietic stem cell transplantation
transplants
neoplasms/therapy
lymphocyte transfusion
review literature